CLINICAL_TRIALS
trial_result
· 2025-09-05
Clinical Trial Update: Reverse Transcriptase Inhibitors in AGS [Phase 2]
Summary
A Phase 2 clinical trial evaluating reverse transcriptase inhibitors in Aicardi-Goutières syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Aicardi-Goutières Syndrome (AGS) | Phase 2 | Status: COMPLETED